Loading clinical trials...

Effectiveness of Continuous Glucose Monitoring System Among Cardiac Surgery Patients | Clinical Trials | Clareo Health

UNKNOWNNA

Effectiveness of Continuous Glucose Monitoring System Among Cardiac Surgery Patients

NCT06275971•Kangbuk Samsung Hospital

Summary

The aim of this study is to assess the level of glycemic control and the incidence of surgery-related complications in cardiac patients post-surgery when Continuous Glucose Monitoring (CGM) is utilized, as compared to traditional methods of arterial/venous blood sampling and Point-of-Care Testing (POCT) for glucose monitoring.

Eligibility

Age

18 - No limit years

Sex

ALL

Healthy Volunteers

Inclusion Criteria

•Subjects waiting for Elective Cardiac Surgery (CABG, Cardiac Valve Operation, Congenital heart anomaly surgery, aortic surgery, etc.)
•Subjects over the age of 18
•Patients with type 2 diabetes
•Patients with prediabetes
•1. HbA1c 5.7% or more
•2. fasting blood glucose 100 mg/dL or more
•3. 2 hours 75g-OGTT 140 mg/dL or more

Exclusion Criteria

•Emergency surgery patients
•Patients performing co-operation other than cardiac surgery
•Patients with type 1 diabetes
•Total Pancreatectomy patients
•Patients with high surgical severity (STS score of 8 or more or EURO score of 5 or more)
•Patients who do not consent to the study
•Severe patients who are deemed difficult to continue research during surgery (excluded at the researcher's discretion)
•1. Cases where severe weight gain and severe edema occur after surgery
•2. Cases where the surgery time is significantly longer than average
•3. Cases where cardiopulmonary bypass is used more than once during surgery
+1 more criteria

Locations (1)

Kangbuk Samsung Hospital

Seoul, South Korea

Key Dates

Start Date

November 24, 2022

Primary Completion Date

June 30, 2024

Completion Date

August 31, 2024

Last Updated

February 23, 2024

Enrollment

ESTIMATED participants

Conditions

Cardiac DiseasePreDiabetesDiabetes Mellitus

Interventions

Dexcom G6

DEVICE

SMBG or venous/arterial blood glucose

DEVICE

Contacts

Cheol-Young Park, MD, PhD

CONTACT

+82220011550 cydoctor68@gmail.com

Sun Joon Moon, MD

CONTACT

+82220011550 ipleat.m@gmail.com

Feasibility of a Tailored Online Self-compassion Intervention

NCT07051005

Type 1 Diabetes MellitusType 2 Diabetes Mellitus (T2DM)

View study

RECRUITING

Genetic Studies of Insulin and Diabetes

NCT00001987

Diabetes MellitusSevere Insulin Resistance

View study

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: February 23, 2024Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions

Effectiveness of Continuous Glucose Monitoring System Among Cardiac Surgery Patients

Inclusion Criteria

Exclusion Criteria

Feasibility of a Tailored Online Self-compassion Intervention

Genetic Studies of Insulin and Diabetes

Mesenchymal Stem Cell and Exosome Therapy for Diabetic Erectile Dysfunction

Pharmacogenetics of the Response to GLP-1 in Mexican-Americans With Prediabetes

A Safety, Tolerability, and Efficacy Study of VX-880 in Participants With Type 1 Diabetes

Fasted Exercise Training in Type 1 Diabetes (FED-T1D)